Correlation Between Neurobo Pharmaceuticals and Longeveron LLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Longeveron LLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Longeveron LLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Longeveron LLC, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Longeveron LLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Longeveron LLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Longeveron LLC.

Diversification Opportunities for Neurobo Pharmaceuticals and Longeveron LLC

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Neurobo and Longeveron is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Longeveron LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Longeveron LLC and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Longeveron LLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Longeveron LLC has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Longeveron LLC go up and down completely randomly.

Pair Corralation between Neurobo Pharmaceuticals and Longeveron LLC

Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.97 times more return on investment than Longeveron LLC. However, Neurobo Pharmaceuticals is 1.03 times less risky than Longeveron LLC. It trades about 0.04 of its potential returns per unit of risk. Longeveron LLC is currently generating about -0.07 per unit of risk. If you would invest  222.00  in Neurobo Pharmaceuticals on September 16, 2024 and sell it today you would earn a total of  4.00  from holding Neurobo Pharmaceuticals or generate 1.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy85.71%
ValuesDaily Returns

Neurobo Pharmaceuticals  vs.  Longeveron LLC

 Performance 
       Timeline  
Neurobo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurobo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Longeveron LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Longeveron LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Longeveron LLC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Neurobo Pharmaceuticals and Longeveron LLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurobo Pharmaceuticals and Longeveron LLC

The main advantage of trading using opposite Neurobo Pharmaceuticals and Longeveron LLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Longeveron LLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Longeveron LLC will offset losses from the drop in Longeveron LLC's long position.
The idea behind Neurobo Pharmaceuticals and Longeveron LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance